The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
The University of Manchester is a higher education institution in the UK. Our Vision – We will be recognised globally for the excellence of our people, research, learning and innovation, and for the benefits we bring to society and the environment. Our purpose – To advance education, knowledge and wisdom for the good of society. Our three core goals are research and discovery, teaching and learning, and social responsibility.
Asthma\COPD\Immunology\Infection
Global fellowships (return phase only)/European fellowships – in line with current status
Respiratory Medicine at University of Manchester covers respiratory broadly, being linked to the NW Lung Centre; one of the largest clinical centres in Europe with 50+ consultants and 12 professors. We work with biomarkers in blood, sputum and exhaled breath and have facilities for early phase clinical trials at the NIHR Manchester CRF, linking the Respiratory Theme of the NIHR Manchester BRC and its research in experimental medicine with the clinic. We have a Unit for antimicrobial resistance research, link with the Lydia Becker Institute on Inflammation and will shortly have access to a 3T MRI scanner for cardiorespiratory research.
The centre has access to a number of clinical resources for research. We have a biobank with blood sputum and tissue samples available for research, access to state-of-the-art physiology as well as a new 3T MRI research scanner. We have several lab facilities and through the NIHR Manchester CRF funding for basic research costs. The NW Lung Centre Charity funds numerous projects in Respiratory Medicine, also linking with NIHR funding for our BRC, CRF and antimicrobial resistance centre.
Many of the centre’s PIs have close links to Industry, Pharmaceutical as well as Devices and we have previously had secondments with pharmaceutical companies. We also work closely with the Medicines Evaluation Unit, an SME specialized in early phase clinical trials. Through the Manchester BRC’s Business Engagement office there are additional opportunities.
The centre has previously hosted international researchers, most notably in the centre’s respiratory fungal unit but also in areas of asthma and COPD. Our PIs all have international collaborations with opportunities for exchange programs.
Yes
